Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells

Journal of Inorganic Biochemistry

Volumn 113, Issue , 2012, Pages 94-101

  Gatti, Laura ^a   Benedetti, Valentina ^a   De Cesare, Michelandrea ^a   Corna, Elisabetta ^a   Cincinelli, Raffaella ^a   Zaffaroni, Nadia ^a   Zunino, Franco ^a   Perego, Paola ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cisplatin; Drug resistance; Ovarian carcinoma

Indexed keywords

BORTEZOMIB; CASPASE 3; HISTONE DEACETYLASE INHIBITOR; MUTANT PROTEIN; PIFITHRIN ALPHA; PLATINUM; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAX; PROTEIN P53; ST 2782; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CARCINOMA CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME DEGRADATION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MONOTHERAPY; MOUSE; NONHUMAN; OVARY CARCINOMA; PROTEIN FUNCTION; TRANSACTIVATION; TRANSCRIPTION TERMINATION; WILD TYPE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOTHIAZOLES; BORONIC ACIDS; CARCINOMA; CASPASE 3; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 84862290994     PISSN: 01620134     EISSN: 18733344     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2012.04.007     Document Type: Article

References (38)

1. T.J. Herzog Curr. Oncol. Rep. 8 2006 448 454
2. A.J. Frew, R.W. Johnstone, and J.E. Bolden Cancer Lett. 280 2009 125 133
3. T. Jenuwein, and C.D. Allis Science 293 2001 1074 1080
4. D. Hanahan, and R.A. Weinberg Cell 100 2000 57 70
5. T. Kouzarides EMBO J. 19 2000 1176 1179
6. W.S. Xu, R.B. Parmigiani, and P.A. Marks Oncogene 26 2007 5541 5552
7. J.E. Bolden, M.J. Peart, and R.W. Johnstone Nat. Rev. Drug Discov. 5 2006 769 784
8. J. Schemies, W. Sippl, and M. Jung Cancer Lett. 280 2009 222 232
9. O.H. Kramer, M. Gottlicher, and T. Heinzel Trends Endocrinol. Metab. 12 2001 294 300
10. M. Ocker, and R. Schneider-Stock Int. J. Biochem. Cell Biol. 39 2007 1367 1374
11. J.S. You, J.K. Kang, E.K. Lee, J.C. Lee, S.H. Lee, Y.J. Jeon, D.H. Koh, S.H. Ahn, D.W. Seo, H.Y. Lee, E.J. Cho, and J.W. Han Oncogene 27 2008 1376 1386
12. L. Nolan, P.W.M. Johnson, A. Ganesan, G. Packham, and S.J. Crabb Br. J. Cancer 99 2008 689 694
13. P.A. Marks, and M. Dokmanovic Expert Opin. Investig. Drugs 14 2005 1497 1511
14. J.S. Carew, F.J. Giles, and S.T. Nawrocki Cancer Lett. 269 2008 7 17
15. U. Lassen, L.R. Molife, M. Sorensen, S.A. Engelholm, L. Vidal, R. Sinha, R.T. Penson, P. Buhl-Jensen, E. Crowley, J. Tjornelund, P. Knoblauch, and J.S. De Bono Br. J. Cancer 103 2010 12 17
16. J. Kim, J. Guan, I. Chang, X. Chen, D. Han, and C.Y. Wang Mol. Cancer Ther. 9 2010 1977 1984
17. Y. Dai, S. Chen, L. Wang, X.Y. Peng, L.B. Kramer, P. Dent, and S. Grant Br. J. Haematol. 153 2011 222 235
18. J. Adams Nat. Rev. Cancer 4 2004 349 360
19. R.Z. Orlowski, and D.J. Kuhn Clin. Cancer Res. 14 2008 1649 1657
20. P.F. Bross, R. Kane, A.T. Farrell, S. Abraham, K. Benson, M.E. Brower, S. Bradley, J.V. Gobburu, A. Goheer, S.L. Lee, J. Leighton, C.Y. Liang, R.T. Lostritto, W.D. McGuinn, D.E. Morse, A. Rahman, L.A. Rosario, S.L. Verbois, G. Williams, Y.C. Wang, and R. Pazdur Clin. Cancer Res. 10 2004 3954 3964
21. W.K. Rasheed, R.W. Johnstone, and H.M. Prince Expert Opin. Investig. Drugs 16 2007 659 678
22. A. Gozzetti, M. Defina, M. Bocchia, A. Fabbri, E. Marchini, I. Chitarrelli, and F. Lauria Leuk. Res. 34 2010 288 289
23. S. Dallavalle, R. Cincinelli, R. Nannei, L. Merlini, G. Morini, S. Penco, C. Pisano, L. Vesci, M. Barbarino, V. Zuco, M. De Cesare, and F. Zunino Eur. J. Med. Chem. 44 2009 1900 1912
24. V. Zuco, V. Benedetti, M. De Cesare, and F. Zunino Int. J. Cancer 126 2010 1246 1255
25. V. Benedetti, P. Perego, G.L. Beretta, E. Corna, S. Tinelli, S.C. Righetti, R. Leone, P. Apostoli, C. Lanzi, and F. Zunino Mol. Cancer Ther. 7 2008 679 687
26. D.R. Walker, J.P. Bond, R.E. Tarone, C.C. Harris, W. Makalowski, and M.S. Boguski Oncogene 18 1999 211 218
27. T.C. Chou, and P. Talalay Adv. Enzyme Regul. 22 1984 27 55
28. E. Giovannetti, C. Lemos, C. Tekle, K. Smid, S. Nannizzi, J.A. Rodriguez, S. Ricciardi, R. Danesi, G. Giaccone, and G.J. Peters Mol. Pharmacol. 73 2008 1290 1300
29. D.A. Fennel, A. Chacko, and L. Mutti Oncogene 27 2008 1189 1197
30. Y. Zhao, J. Tan, L. Zhuang, X. Jiang, E.T. Liu, Y. Qu, and Bim Proc. Natl. Acad. Sci. U. S. A. 102 2005 16090 16095
31. A.V. Gudkov, and E.A. Komarova Biochem. Biophys. Res. Commun. 331 2005 726 736
32. C.Y. Gui, L. Ngo, W.S. Xu, V.M. Richon, and P.A. Marks Proc. Natl. Acad. Sci. U. S. A. 101 2004 1241 1246
33. M. Giuliano, M. Lauricella, G. Calvaruso, M. Carabillò, S. Emanuele, R. Vento, and G. Tesoriere Cancer Res. 59 1999 5586 5595
34. C. Boyault, K. Sadoul, M. Pabion, and S. Khochbin Oncogene 26 2007 5468 5476
35. M. Bazzaro, Z. Lin, A. Santillan, M.K. Lee, M.-C. Wang, K.C. Chan, R.E. Bristow, R. Mazitschek, J. Bradner, and R.B. Roden Clin. Cancer Res. 14 2008 7340 7347
36. M. Mahyar-Roemer, and K. Roemer Oncogene 20 2001 3387 3398
37. V. Zuco, M. De Cesare, R. Cincinelli, R. Nannei, C. Pisano, N. Zaffaroni, and F. Zunino PLoS One 6 2011 e29085
38. H. Yamaguchi, N.T. Woods, L.G. Piluso, H.H. Lee, J. Chen, K.N. Bhalla, A. Monteiro, X. Liu, M.C. Hung, and H.G. Wang J. Biol. Chem. 284 2009 11171 11183